Author = Hadi Karami
Number of Articles: 7
1. Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells

Volume 23, Issue 7, July 2022, Pages 2523-2530

Behzad Baradaran; Roya Nazmabadi; Zohreh Ariyan; Ebrahim Sakhinia; Hadi Karami


2. Combination Therapy with PIK3R3-siRNA and EGFR-TKI Erlotinib Synergistically Suppresses Glioblastoma Cell Growth In Vitro

Volume 22, Issue 12, December 2021, Pages 3993-4000

Razieh Amini; Hadi Karami; Mohammad Bayat


3. MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells

Volume 22, Issue 7, July 2021, Pages 2191-2198

Nooshin Ashofteh; Razieh Amini; Neda Molaee; Hadi Karami; Maryam Baazm


4. MiRNA-7 Replacement Effect on Proliferation and Tarceva-Sensitivity in U373-MG Cell Line

Volume 21, Issue 6, June 2020, Pages 1747-1753

Vahab Alamdari-Palangi; Zahra Karami; Hadi Karami; Maryam Baazm


5. Gene Therapy with MiRNA-Mediated Targeting of Mcl-1 Promotes the Sensitivity of Non-Small Cell Lung Cancer Cells to Treatment with ABT-737

Volume 21, Issue 3, March 2020, Pages 675-681

Mahshid Shahverdi; Razieh Amini; Jamal Amri; Hadi Karami


7. Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib

Volume 20, Issue 9, September 2019, Pages 2781-2787

Jamal Amri; Neda Molaee; Maryam Baazm; Hadi Karami